Diazepam | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Diazepam
Health Canada Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Diazepam

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

18 API Suppliers, 7 USDMF, 4 CEP/COS, 2 JDMF, 3 EU WC, 9 NDC API, 14 Listed Suppliers, $ API Reference Price

18 API Suppliers
7 USDMF
4 CEP/COS
2 JDMF
3 EU WC
9 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

358 FDF Dossiers, 128 FDA Orange Book, 129 Europe, 15 Canada, 31 Australia, 18 South Africa, 37 Listed Dossiers

358 FDF Dossiers
128 FDA Orange Book
129 Europe
15 Canada
31 Australia
18 South Africa
37 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2MG, TABLET;ORAL - 5MG, GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 2.5MG/0.5ML (5MG/ML), GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 2MG
TABLET;ORAL - 5MG
GEL;RECTAL - 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 2.5MG/0.5ML (5MG/ML)
GEL;RECTAL - 20MG/4ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;RECTAL - 5MG/ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 6 SPI Pharma, 3 DKSH, 5 Faran Shimi Pharmaceutical, 6 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 2 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 3 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 26 Disintegrants & Superdisintegrants, 25 Controlled & Modified Release, 21 Thickeners and Stabilizers, 21 Direct Compression, 19 Granulation, 18 Lubricants & Glidants, 18 Film Formers & Plasticizers, 16 Topical, 13 Taste Masking, 11 Co-Processed Excipients, 9 Solubilizers, 8 Chewable & Orodispersible Aids, 7 Parenteral, 6 Rheology Modifiers, 6 Emulsifying Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

61 Fillers, Diluents & Binders
47 Coating Systems & Additives
26 Disintegrants & Superdisintegrants
25 Controlled & Modified Release
21 Thickeners and Stabilizers
21 Direct Compression
19 Granulation
18 Lubricants & Glidants
18 Film Formers & Plasticizers
16 Topical
13 Taste Masking
11 Co-Processed Excipients
9 Solubilizers
8 Chewable & Orodispersible Aids
7 Parenteral
6 Rheology Modifiers
6 Emulsifying Agents
5 Empty Capsules
4 Vegetarian Capsules
4 API Stability Enhancers
2 Surfactant & Foaming Agents
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 70 News #PharmaBuzz

1 Data Compilation #PharmaFlow
70 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 136 Regulatory FDF Prices, 3 Annual Reports

4 US Medicaid Prescriptions
136 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

31 APIs, 24 FDF Dossiers

31 APIs
24 FDF Dossiers

PATENTS & EXCLUSIVITIES

23 US Patents, 13 US Exclusivities, 1 Health Canada Patents

23 US Patents
13 US Exclusivities
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 10 Others

2 EDQM
2 USP
10 Others

$ API Ref.Price (USD/KG) : 216 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Valeant Canada LP

filter Patent Reset all filters

1 All

01 12171627

filter Product Reset all filters

1 All

01 1Diazepam

filter Dosage Reset all filters

1 All

01 1Gel

filter Exp Date Reset all filters

1 All

01 12014-09-12

Product Main Page

01

Valeant Canada LP

Diazepam

Conjugates Summit

Not Confirmed

Valeant Canada LP

Conjugates Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-09-12

Date Granted : 2006-01-31

Brand Name : DIASTAT RECTAL DELIVERY SYSTEM

Patent Number : 2171627

Filing Date : 1994-09-12

Strength per Unit : 5mg/ml

Dosage Form : Gel

Human Or VET : Human

Route of Administration : Rectal

Patent Expiration Date : 2014-09-12

Date Granted : 2006-01-31

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!